Literature DB >> 22227697

Tricyclo[3.2.2.0(2,4)]non-8-en-6,7-dicarbonic acid derivatives efficiently inhibits the replication of different orthopoxvirus species.

B A Selivanov1, E F Belanov, N I Bormotov, S M Balakhnin, O A Serova, V A Svyatchenko, N N Kiselev, E I Kazachinskaya, V B Loktev, A Ya Tikhonov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22227697     DOI： 10.1134/S0012496611060135

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  8 in total

1.  In vitro and in vivo evaluation of isatin-beta-thiosemicarbazone and marboran against vaccinia and cowpox virus infections.

Authors:  Debra C Quenelle; Kathy A Keith; Earl R Kern
Journal:  Antiviral Res       Date:  2006-03-29       Impact factor: 5.970

2.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 3.  Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy.

Authors:  C M Lange; C Sarrazin; S Zeuzem
Journal:  Aliment Pharmacol Ther       Date:  2010-03-31       Impact factor: 8.171

Review 4.  Human monkeypox: an emerging zoonosis.

Authors:  Daniel B Di Giulio; Paul B Eckburg
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

Review 5.  Zoonotic poxvirus infections in humans.

Authors:  Sue Lewis-Jones
Journal:  Curr Opin Infect Dis       Date:  2004-04       Impact factor: 4.915

6.  Cidofovir inhibits genome encapsidation and affects morphogenesis during the replication of vaccinia virus.

Authors:  Desyreé Murta Jesus; Lilian T Costa; Daniela L Gonçalves; Carlos Alberto Achete; Marcia Attias; Nissin Moussatché; Clarissa R Damaso
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

7.  An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.

Authors:  Guang Yang; Daniel C Pevear; Marc H Davies; Marc S Collett; Tom Bailey; Susan Rippen; Linda Barone; Chris Burns; Gerry Rhodes; Sanjeev Tohan; John W Huggins; Robert O Baker; R L Mark Buller; Erin Touchette; Kem Waller; Jill Schriewer; Johan Neyts; Erik DeClercq; Kevin Jones; Dennis Hruby; Robert Jordan
Journal:  J Virol       Date:  2005-10       Impact factor: 6.549

8.  N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors.

Authors:  Thomas R Bailey; Susan R Rippin; Elizabeth Opsitnick; Christopher J Burns; Daniel C Pevear; Marc S Collett; Gerry Rhodes; Sanjeev Tohan; John W Huggins; Robert O Baker; Earl R Kern; Kathy A Keith; Dongcheng Dai; Guang Yang; Dennis Hruby; Robert Jordan
Journal:  J Med Chem       Date:  2007-03-03       Impact factor: 8.039
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.